Persistence with mirabegron or antimuscarinic treatment for overactive bladder syndrome: Findings from the PERSPECTIVE registry study-Reference-Cited by-同舟云学术

Persistence with mirabegron or antimuscarinic treatment for overactive bladder syndrome: Findings from the PERSPECTIVE registry study

Published:2021-05-14 Issue:4 Volume:13 Page:425-434
ISSN:1757-5664
Container-title:LUTS: Lower Urinary Tract Symptoms
language:en
Short-container-title:Lower Urinary Tract Symptoms

Author:

Carlson Kevin V.¹,Rovner Eric S.²,Nair Kavita V.³,Deal Anna S.⁴,Kristy Rita M.⁵,Hairston John C.⁵

Affiliation:

1. Section of Urology, Department of Surgery University of Calgary Calgary Alberta Canada

2. Department of Urology Medical University of South Carolina Charleston South Carolina USA

3. Center for Pharmaceutical Outcomes Research, Department of Clinical Pharmacy University of Colorado, Anschutz Medical Campus, Skaggs School of Pharmacy and Pharmaceutical Sciences Aurora Colorado USA

4. IPC/TeamHealth Johnson City Tennessee USA

5. Astellas Pharma Global Development, Inc. Northbrook Illinois USA

Funder

Astellas Pharma Global Development

Publisher

Wiley

Subject

Urology,Neurology

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1111/luts.12382

Reference46 articles.

1. Do we need a new definition of the overactive bladder syndrome? ICI-RS 2013

2. Overactive Bladder Syndrome: Evaluation and Management

3. A population-based study of urinary symptoms and incontinence: the Canadian Urinary Bladder Survey

4. National Community Prevalence of Overactive Bladder in the United States Stratified by Sex and Age

5. The impact of overactive bladder, incontinence and other lower urinary tract symptoms on quality of life, work productivity, sexuality and emotional well-being in men and women: results from the EPIC study

Cited by 20 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Effects of long‐term desmopressin treatment for nocturia in older people;International Journal of Urology;2024-07-15

2. Comparative analysis of real‐world adherence and persistence patterns with vibegron, mirabegron, and anticholinergics in patients with overactive bladder: A retrospective claims study;Neurourology and Urodynamics;2024-05-08

3. Predictors of non-persistence in women with overactive bladder syndrome;Scientific Reports;2024-03-29

4. Real-World Adherence to and Persistence with Vibegron in Patients with Overactive Bladder: A Retrospective Claims Analysis;Advances in Therapy;2024-03-23

5. Treatment Patterns with Mirabegron and Antimuscarinics for Overactive Bladder: A Prospective, Registry Study in Taiwan and South Korea (FAITH);Advances in Therapy;2024-03-02